The characteristics and mechanism of co-administration of lovastatin solid dispersion with kaempferol to increase oral bioavailability

References

• Chen AY, Chen YC. (2013). A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chemistry 138:2099–107.
   PubMed Web of Science ®Google Scholar
• Choi DH, Chung JH, Choi JS. (2010). Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin. Eur J Clin Pharmacol 66:285–90.
   PubMed Web of Science ®Google Scholar
• Choi JS, Park JS. (2017). Design of PVP/VA S-630 based tadalafil solid dispersion to enhance the dissolution rate. Eur J Pharm Sci 97:269–76.
   PubMed Web of Science ®Google Scholar
• Iñigo C, Barber A, Lostao MP. (2006). Na + and pH dependence of proline and beta-alanine absorption in rat small intestine. Acta Physiol 186:271–8.
   PubMed Web of Science ®Google Scholar
• Dangprasirt P, Ritthidej GC. (1995). Development of diclofenac sodium controlled release solid dispersions by spray drying using optimization strategy I. Powder formulation. Drug Develop Ind Pharm 21:2323–37.
   Web of Science ®Google Scholar
• Duggan DE, Chen IW, Bayne WF, et al. (1989). The physiological disposition of lovastatin. Drug Metab Dispos 17:166–73.
   PubMed Web of Science ®Google Scholar
• Generaux GT, Bonomo FM, Johnson M, et al. (2011). Impact of SLCO1B1 (OATP1B1) and ABCG2 (BCRP) genetic polymorphisms and inhibition on LDL-C lowering and myopathy of statins. Xenobiotica 41:639–51.
   PubMed Web of Science ®Google Scholar
• Huang S, Zhang Q, Li H, et al. (2018). Increased bioavailability of efonidipine hydrochloride nanosuspensions by the wet-milling method. Eur J Pharm Biopharm 130:108–14.
   PubMed Web of Science ®Google Scholar
• Huang ZR. (2010). Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. Eur J Pharm Biopham 74:474–82.
   PubMed Web of Science ®Google Scholar
• Ieiri I, Higuchi S, Sugiyama Y. (2009). Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs. Exper Opin Drug Metab Toxicol 5:703–29.
   PubMed Web of Science ®Google Scholar
• Kashyap D, Sharma A, Tuli HS, et al. (2017). Kaempferol - A dietary anticancer molecule with multiple mechanisms of action: Recent trends and advancements. J Function Foods 30:203–19.
   PubMed Web of Science ®Google Scholar
• Kim SH, Hwang KA, Choi KC. (2016). Treatment with kaempferol suppresses breast cancer cell growth caused by estrogen and triclosan in cellular and xenograft breast cancer models. J Nutr Biochem 28:70–82.
   PubMed Web of Science ®Google Scholar
• Lennernäs DH, Fager G. (1997). Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences. Clin Pharm 32:403–25.
   Google Scholar
• Leone G, Consumi M, Franzi C, et al. (2018). Development of liposomal formulations to potentiate natural lovastatin inhibitory activity towards 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase. J Drug Deliv Sci Technol 43:107–12.
   Web of Science ®Google Scholar
• Leppert PS, Fix JA. (1994). Use of everted intestinal rings for in vitro examination of oral absorption potential. J Pharm Sci 83:976–81.
   PubMed Web of Science ®Google Scholar
• Liu JW, Zou MJ, Piao HY, et al. (2015). Characterization and pharmacokinetic study of aprepitant solid dispersions with soluplus®. Molecules 20:11345–56.
   PubMed Web of Science ®Google Scholar
• Manoela KR. (2014). HPMC as a potential enhancer of nimodipine biopharmaceutical properties via ball-milled solid dispersions. Carbohydr Polym 99:474–82.
   PubMed Web of Science ®Google Scholar
• Molina AJ, Merino G, Prieto JG, et al. (2007). Absorption and metabolism of albendazole after intestinal ischemia/reperfusion. Eur J Pharm Sci 31:16–24.
   PubMed Web of Science ®Google Scholar
• Mukhtar H, Ijaz SS. Ikram-Ul-Haq  (2014). Upstream and downstream processing of lovastatin by aspergillus terreus. Cell Biochem Biophys 70:309–20.
   PubMed Web of Science ®Google Scholar
• Solanki NG, Lam K, Tahsin M, et al. (2019a). Effects of surfactants on itraconazole-HPMCAS solid dispersion prepared by hot-melt extrusion I: miscibility and drug release J Pharm Sci 108:1453–65.
   PubMed Web of Science ®Google Scholar
• Solanki NG, Gumaste SG, Shah AV, et al. (2019b). Effects of surfactants on itraconazole-hydroxypropyl methylcellulose acetate succinate solid dispersion prepared by hot melt extrusion. II: rheological analysis and extrudability testing. J Pharm Sci 108:3063–73.
   PubMed Web of Science ®Google Scholar
• Pal D, Mitra AK. (2006). MDR- and CYP3A4-mediated drug-herbal interactions. Life Sci 78:2131–45.
   PubMed Web of Science ®Google Scholar
• Patel M, Tekade A, Gattani S, et al. (2008). Solubility enhancement of lovastatin by modified locust bean gum using solid dispersion techniques. AAPS Pharmscitech 9:1262–9.
   PubMed Web of Science ®Google Scholar
• Patel RP, Patel MM. (2007). Physicochemical characterization and dissolution study of solid dispersions of lovastatin with polyethylene glycol 4000 and polyvinylpyrrolidone K30. Pharm Dev Technol 12:21–33.
   PubMed Web of Science ®Google Scholar
• Polli JW, Hussey E, Bush M, et al. (2013). Evaluation of drug interactions of GSK1292263 (a GPR119 agonist) with statins: from in vitro data to clinical study design. Xenobiotica 43:498–508.
   PubMed Web of Science ®Google Scholar
• Roger E, Lagarce F, Garcion E, et al. (2009). Lipid nanocarriers improve paclitaxel transport throughout human intestinal epithelial cells by using vesicle-mediated transcytosis. J Control Rel 140:174–81.
   PubMed Web of Science ®Google Scholar
• Rui J, Peng H, Guisheng Y, et al. (2019). Kaempferol protects chondrogenic ATDC5 cells against inflammatory injury triggered by lipopolysaccharide through down-regulating miR-146a. Int Immunopharmacol 69:373–81.
   PubMed Web of Science ®Google Scholar
• Stoja M, Jelena D, Aleksandra D, et al. (2019). Soluplus®, Eudragit®, HPMCAS foams and solid dispersions for enhancement of Carvedilol dissolution rate prepared by a supercritical CO2 process. Poly Testing 76:54–64.
   Web of Science ®Google Scholar
• Teófilo V, Sarmento B, Costa P. (2007). Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Discov Today 12:1068–75.
   PubMed Web of Science ®Google Scholar
• Tu YC, Lian TW, Yen JH, et al. (2007). Antiatherogenic effects of kaempferol and rhamnocitrin. J. Agric Food Chem 55:9969–76.
   PubMed Web of Science ®Google Scholar
• Vidyadhara S, Reddy GVR, Chandana AR. (2011). Formulation and evaluation of lovastatin fast dissolving tablets using newer super disintegrants. J Pharm Res 6:1762–5.
   Google Scholar
• Von Moltke LL, Weemhoff JL, Bedir E, et al. (2010). Inhibition of human cytochromes P450 by components of Ginkgo biloba. J Pharm Pharmacol 56:1039–44.
   Web of Science ®Google Scholar
• Wang RW, Kari PH, Lu AY, et al. (1991). Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes. Arch Biochem Biophys 290:355–61.
   PubMed Web of Science ®Google Scholar
• Wu CY, Benet LZ. (2010). Predicting drug disposition via application of BCS: transport/absorption/ elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 106:162–7.
   Google Scholar
• Zhang FF, Zheng YF, Hj ZHU, et al. (2006). Effects of kaempferol and quercetin on cytochrome 450 activities in primarily cultured rat hepatocytes. J Zhejiang Univ Med Sci 35:18–22.
   Google Scholar
• Zhang Z, Bu H, Gao Z, et al. (2010). The characteristics and mechanism of simvastatin loaded lipid nanoparticles to increase oral bioavailability in rats. Int J Pharm 394:147–53.
   PubMed Web of Science ®Google Scholar